InsidersTradesSigma
Follow the 信邦制药 stock price and the full directors' dealings record of the company, a listed issuer based in China. Shares trade on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 信邦制药 has published 2 public disclosures. Market capitalisation: €5.8bn. The latest transaction was disclosed on 23 May 2022 (Purchase). Among the most active insiders: 高文林. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
信邦制药 is a company specializing in the health and pharmaceutical sector, providing innovative pharmaceutical products. It is listed on the XSHE market.